Antimicrobial Peptide Therapeutics for Cystic Fibrosis

Greater than 90% of lung infections in cystic fibrosis (CF) patients are caused by Pseudomonas aeruginosa, and the majority of these patients subsequently die from lung damage. Current therapies are either targeted at reducing obstruction, reducing inflammation, or reducing infection. To identify po...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Zhang, Lijuan, Parente, Jody, Harris, Scott M., Woods, Donald E., Hancock, Robert E. W., Falla, Timothy J.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2005
Teme:
Experimental Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1168697/
https://ncbi.nlm.nih.gov/pubmed/15980369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.7.2921-2927.2005
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items